Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1963 1
1964 1
1965 3
1966 2
1968 3
1969 6
1970 2
1971 1
1972 5
1973 7
1974 2
1975 2
1976 1
1977 1
1978 5
1979 3
1980 2
1981 5
1982 6
1983 1
1984 7
1985 4
1986 7
1987 3
1989 1
1990 2
1991 2
1992 1
1993 2
1994 4
1995 6
1996 2
1997 2
1998 2
2000 6
2001 4
2002 2
2006 4
2007 2
2008 3
2009 1
2010 1
2012 4
2013 9
2014 11
2015 11
2016 14
2017 23
2018 26
2019 24
2020 27
2021 26
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

278 results
Results by year
Filters applied: . Clear all
Page 1
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy.
Torlakovic E, Lim HJ, Adam J, Barnes P, Bigras G, Chan AWH, Cheung CC, Chung JH, Couture C, Fiset PO, Fujimoto D, Han G, Hirsch FR, Ilie M, Ionescu D, Li C, Munari E, Okuda K, Ratcliffe MJ, Rimm DL, Ross C, Røge R, Scheel AH, Soo RA, Swanson PE, Tretiakova M, To KF, Vainer GW, Wang H, Xu Z, Zielinski D, Tsao MS. Torlakovic E, et al. Among authors: fujimoto d. Mod Pathol. 2020 Jan;33(1):4-17. doi: 10.1038/s41379-019-0327-4. Epub 2019 Aug 5. Mod Pathol. 2020. PMID: 31383961 Free PMC article. Review.
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical Trial.
Akamatsu H, Toi Y, Hayashi H, Fujimoto D, Tachihara M, Furuya N, Otani S, Shimizu J, Katakami N, Azuma K, Miura N, Nishino K, Hara S, Teraoka S, Morita S, Nakagawa K, Yamamoto N. Akamatsu H, et al. Among authors: fujimoto d. JAMA Oncol. 2021 Mar 1;7(3):386-394. doi: 10.1001/jamaoncol.2020.6758. JAMA Oncol. 2021. PMID: 33410885 Free PMC article.
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study.
Ito K, Yamanaka T, Hayashi H, Hattori Y, Nishino K, Kobayashi H, Oya Y, Yokoyama T, Seto T, Azuma K, Fukui T, Kozuki T, Nakamura A, Tanaka K, Hirano K, Yokoi T, Daga H, Sakata S, Fujimoto D, Mori M, Maeno K, Aoki T, Tamura A, Miura S, Watanabe S, Akamatsu H, Hataji O, Suzuki K, Hontsu S, Azuma K, Bessho A, Kubo A, Okuno M, Nakagawa K, Yamamoto N. Ito K, et al. Among authors: fujimoto d. Eur J Cancer. 2021 Mar;145:183-193. doi: 10.1016/j.ejca.2020.12.026. Epub 2021 Jan 22. Eur J Cancer. 2021. PMID: 33486442
Recurrence risk factors in stage IA grade 1 endometrial cancer.
Nwachukwu C, Baskovic M, Von Eyben R, Fujimoto D, Giaretta S, English D, Kidd E. Nwachukwu C, et al. Among authors: fujimoto d. J Gynecol Oncol. 2021 Mar;32(2):e22. doi: 10.3802/jgo.2021.32.e22. Epub 2021 Jan 8. J Gynecol Oncol. 2021. PMID: 33470064 Free PMC article.
Aprepitant for refractory nivolumab-induced pruritus.
Ito J, Fujimoto D, Nakamura A, Nagano T, Uehara K, Imai Y, Tomii K. Ito J, et al. Among authors: fujimoto d. Lung Cancer. 2017 Jul;109:58-61. doi: 10.1016/j.lungcan.2017.04.020. Epub 2017 Apr 27. Lung Cancer. 2017. PMID: 28577951
Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors.
Chin AL, Fujimoto D, Kumar KA, Tupper L, Mansour S, Chang SD, Adler JR, Gibbs IC, Hancock SL, Dodd R, Li G, Gephart MH, Ratliff JK, Tse V, Usoz M, Sachdev S, Soltys SG. Chin AL, et al. Among authors: fujimoto d. Neurosurgery. 2019 Nov 1;85(5):708-716. doi: 10.1093/neuros/nyy442. Neurosurgery. 2019. PMID: 30445557
278 results